2014-2026 Global Hereditary Angioedema Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-14973639 | Published Date: 06-Dec-2019 | No. of pages: 110
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Hereditary Angioedema Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Hereditary Angioedema Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Hereditary Angioedema Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Hereditary Angioedema Market-Segmentation by Type 5.1 Type I HAE 5.2 Type II HAE 5.3 Type III HAE 6 Global Hereditary Angioedema Market-Segmentation by Application 6.1 Hospitals 6.2 clinics 6.3 Research centers 7 Global Hereditary Angioedema Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 iBio 8.1.1 iBio Profile 8.1.2 iBio Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 iBio Product/Solution Launches and Enhancements Analysis 8.1.4 iBio Business Overview/Recent Development/Acquisitions 8.2 Sanofi N.V. 8.2.1 Sanofi N.V. Profile 8.2.2 Sanofi N.V. Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Sanofi N.V. Product/Solution Launches and Enhancements Analysis 8.2.4 Sanofi N.V. Business Overview/Recent Development/Acquisitions 8.3 Pharming Group 8.3.1 Pharming Group Profile 8.3.2 Pharming Group Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Pharming Group Product/Solution Launches and Enhancements Analysis 8.3.4 Pharming Group Business Overview/Recent Development/Acquisitions 8.4 Merck & Co., Inc. 8.4.1 Merck & Co., Inc. Profile 8.4.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis 8.4.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions 8.5 Cipla, Inc. 8.5.1 Cipla, Inc. Profile 8.5.2 Cipla, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Cipla, Inc. Product/Solution Launches and Enhancements Analysis 8.5.4 Cipla, Inc. Business Overview/Recent Development/Acquisitions 8.6 Ionis Pharmaceuticals 8.6.1 Ionis Pharmaceuticals Profile 8.6.2 Ionis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Ionis Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.6.4 Ionis Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.7 Shire 8.7.1 Shire Profile 8.7.2 Shire Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Shire Product/Solution Launches and Enhancements Analysis 8.7.4 Shire Business Overview/Recent Development/Acquisitions 8.8 CSL 8.8.1 CSL Profile 8.8.2 CSL Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 CSL Product/Solution Launches and Enhancements Analysis 8.8.4 CSL Business Overview/Recent Development/Acquisitions 8.9 ioCryst Pharmaceuticals 8.9.1 ioCryst Pharmaceuticals Profile 8.9.2 ioCryst Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 ioCryst Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.9.4 ioCryst Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.10 Teva Pharmaceutical Industries 8.10.1 Teva Pharmaceutical Industries Profile 8.10.2 Teva Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Teva Pharmaceutical Industries Product/Solution Launches and Enhancements Analysis 8.10.4 Teva Pharmaceutical Industries Business Overview/Recent Development/Acquisitions 9 Global Hereditary Angioedema Market-Segmentation by Geography 10 North America 10.1 North America Hereditary Angioedema Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Hereditary Angioedema Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Hereditary Angioedema Production Analysis from 2014-2019E 10.4 North America Hereditary Angioedema Consumption Analysis from 2014-2019E 10.5 North America Hereditary Angioedema Import and Export from 2014-2019E 10.6 North America Hereditary Angioedema Value, Production and Market Share by Type (2014-2019E) 10.7 North America Hereditary Angioedema Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Hereditary Angioedema by Country (United States, Canada) 10.8.1 North America Hereditary Angioedema Sales by Country (2014-2019E) 10.8.2 North America Hereditary Angioedema Consumption Value by Country (2014-2019E) 10.9 North America Hereditary Angioedema Market PEST Analysis 11 Europe 11.1 Europe Hereditary Angioedema Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Hereditary Angioedema Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Hereditary Angioedema Production Analysis from 2014-2019E 11.4 Europe Hereditary Angioedema Consumption Analysis from 2014-2019E 11.5 Europe Hereditary Angioedema Import and Export from 2014-2019E 11.6 Europe Hereditary Angioedema Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Hereditary Angioedema Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Hereditary Angioedema by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Hereditary Angioedema Sales by Country (2014-2019E) 11.8.2 Europe Hereditary Angioedema Consumption Value by Country (2014-2019E) 11.9 Europe Hereditary Angioedema Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Hereditary Angioedema Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Hereditary Angioedema Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Hereditary Angioedema Production Analysis from 2014-2019E 12.4 Asia-Pacific Hereditary Angioedema Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Hereditary Angioedema Import and Export from 2014-2019E 12.6 Asia-Pacific Hereditary Angioedema Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Hereditary Angioedema Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Hereditary Angioedema by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Hereditary Angioedema Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Hereditary Angioedema Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Hereditary Angioedema Market PEST Analysis 13 Latin America 13.1 Latin America Hereditary Angioedema Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Hereditary Angioedema Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Hereditary Angioedema Production Analysis from 2014-2019E 13.4 Latin America Hereditary Angioedema Consumption Analysis from 2014-2019E 13.5 Latin America Hereditary Angioedema Import and Export from 2014-2019E 13.6 Latin America Hereditary Angioedema Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Hereditary Angioedema Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Hereditary Angioedema by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Hereditary Angioedema Sales by Country (2014-2019E) 13.8.2 Latin America Hereditary Angioedema Consumption Value by Country (2014-2019E) 13.9 Latin America Hereditary Angioedema Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Hereditary Angioedema Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Hereditary Angioedema Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Hereditary Angioedema Production Analysis from 2014-2019E 14.4 Middle East & Africa Hereditary Angioedema Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Hereditary Angioedema Import and Export from 2014-2019E 14.6 Middle East & Africa Hereditary Angioedema Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Hereditary Angioedema Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Hereditary Angioedema by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Hereditary Angioedema Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Hereditary Angioedema Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Hereditary Angioedema Market PEST Analysis 15 Future Forecast of the Global Hereditary Angioedema Market from 2018-2026 15.1 Future Forecast of the Global Hereditary Angioedema Market from 2019-2026 Segment by Region 15.2 Global Hereditary Angioedema Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Hereditary Angioedema Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source
List of Tables and Figures Global Hereditary Angioedema Market Value ($) and Growth Rate of Hereditary Angioedema from 2014-2026 Global Hereditary Angioedema Production and Growth Rate Segment by Product Type from 2014-2026F Global Hereditary Angioedema Consumption and Growth Rate Segment by Application from 2014-2019E Figure Hereditary Angioedema Picture Table Product Specifications of Hereditary Angioedema Table Driving Factors for this Market Table Industry News of Hereditary Angioedema Market Figure Value Chain Status of Hereditary Angioedema Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Hereditary Angioedema Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Hereditary Angioedema Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Type I HAE of Hereditary Angioedema Figure Type II HAE of Hereditary Angioedema Figure Type III HAE of Hereditary Angioedema Table Global Hereditary Angioedema Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Hereditary Angioedema Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospitals of Hereditary Angioedema Figure clinics of Hereditary Angioedema Figure Research centers of Hereditary Angioedema Table Global Hereditary Angioedema Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Hereditary Angioedema Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Hereditary Angioedema Figure Online Channel of Hereditary Angioedema Table iBio Profile (Company Name, Plants Distribution, Sales Region) Figure iBio Sales and Growth Rate from 2014-2019E Figure iBio Revenue ($) and Global Market Share from 2014-2019E Table iBio Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi N.V. Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi N.V. Sales and Growth Rate from 2014-2019E Figure Sanofi N.V. Revenue ($) and Global Market Share from 2014-2019E Table Sanofi N.V. Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pharming Group Profile (Company Name, Plants Distribution, Sales Region) Figure Pharming Group Sales and Growth Rate from 2014-2019E Figure Pharming Group Revenue ($) and Global Market Share from 2014-2019E Table Pharming Group Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck & Co., Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Merck & Co., Inc. Sales and Growth Rate from 2014-2019E Figure Merck & Co., Inc. Revenue ($) and Global Market Share from 2014-2019E Table Merck & Co., Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Cipla, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Cipla, Inc. Sales and Growth Rate from 2014-2019E Figure Cipla, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Cipla, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Ionis Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Ionis Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Ionis Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Ionis Pharmaceuticals Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Shire Profile (Company Name, Plants Distribution, Sales Region) Figure Shire Sales and Growth Rate from 2014-2019E Figure Shire Revenue ($) and Global Market Share from 2014-2019E Table Shire Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table CSL Profile (Company Name, Plants Distribution, Sales Region) Figure CSL Sales and Growth Rate from 2014-2019E Figure CSL Revenue ($) and Global Market Share from 2014-2019E Table CSL Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table ioCryst Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure ioCryst Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure ioCryst Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table ioCryst Pharmaceuticals Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Teva Pharmaceutical Industries Profile (Company Name, Plants Distribution, Sales Region) Figure Teva Pharmaceutical Industries Sales and Growth Rate from 2014-2019E Figure Teva Pharmaceutical Industries Revenue ($) and Global Market Share from 2014-2019E Table Teva Pharmaceutical Industries Hereditary Angioedema Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Hereditary Angioedema Production Value ($) by Region from 2014-2019E Table Global Hereditary Angioedema Production Value Share by Region from 2014-2019E Table Global Hereditary Angioedema Production by Region from 2014-2019E Table Global Hereditary Angioedema Consumption Value ($) by Region from 2014-2019E Table Global Hereditary Angioedema Consumption by Region from 2014-2019E Table North America Hereditary Angioedema Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Hereditary Angioedema Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Hereditary Angioedema Import and Export from 2014-2019E Table North America Hereditary Angioedema Value ($) by Type (2014-2019E) Table North America Hereditary Angioedema Production by Type (2014-2019E) Table North America Hereditary Angioedema Consumption by Application (2014-2019E) Table North America Hereditary Angioedema Consumption by Country (2014-2019E) Table North America Hereditary Angioedema Consumption Value ($) by Country (2014-2019E) Figure North America Hereditary Angioedema Market PEST Analysis Table Europe Hereditary Angioedema Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Hereditary Angioedema Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Hereditary Angioedema Import and Export from 2014-2019E Table Europe Hereditary Angioedema Value ($) by Type (2014-2019E) Table Europe Hereditary Angioedema Production by Type (2014-2019E) Table Europe Hereditary Angioedema Consumption by Application (2014-2019E) Table Europe Hereditary Angioedema Consumption by Country (2014-2019E) Table Europe Hereditary Angioedema Consumption Value ($) by Country (2014-2019E) Figure Europe Hereditary Angioedema Market PEST Analysis Table Asia-Pacific Hereditary Angioedema Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Hereditary Angioedema Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Hereditary Angioedema Import and Export from 2014-2019E Table Asia-Pacific Hereditary Angioedema Value ($) by Type (2014-2019E) Table Asia-Pacific Hereditary Angioedema Production by Type (2014-2019E) Table Asia-Pacific Hereditary Angioedema Consumption by Application (2014-2019E) Table Asia-Pacific Hereditary Angioedema Consumption by Country (2014-2019E) Table Asia-Pacific Hereditary Angioedema Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Hereditary Angioedema Market PEST Analysis Table Latin America Hereditary Angioedema Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Hereditary Angioedema Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Hereditary Angioedema Import and Export from 2014-2019E Table Latin America Hereditary Angioedema Value ($) by Type (2014-2019E) Table Latin America Hereditary Angioedema Production by Type (2014-2019E) Table Latin America Hereditary Angioedema Consumption by Application (2014-2019E) Table Latin America Hereditary Angioedema Consumption by Country (2014-2019E) Table Latin America Hereditary Angioedema Consumption Value ($) by Country (2014-2019E) Figure Latin America Hereditary Angioedema Market PEST Analysis Table Middle East & Africa Hereditary Angioedema Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Hereditary Angioedema Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Hereditary Angioedema Import and Export from 2014-2019E Table Middle East & Africa Hereditary Angioedema Value ($) by Type (2014-2019E) Table Middle East & Africa Hereditary Angioedema Production by Type (2014-2019E) Table Middle East & Africa Hereditary Angioedema Consumption by Application (2014-2019E) Table Middle East & Africa Hereditary Angioedema Consumption by Country (2014-2019E) Table Middle East & Africa Hereditary Angioedema Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Hereditary Angioedema Market PEST Analysis Table Global Hereditary Angioedema Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Hereditary Angioedema Production and Growth Rate Forecast by Region (2019-2026) Table Global Hereditary Angioedema Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Hereditary Angioedema Production and Growth Rate Forecast by Type (2019-2026) Table Global Hereditary Angioedema Consumption and Growth Rate Forecast by Application (2019-2026)
  • PRICE
  • $3460
    $5000
    Buy Now

Our Clients